Vijender Panduga

Author PubWeight™ 8.81^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.	Antimicrob Agents Chemother	2013	1.10
2	Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.	J Med Chem	2013	0.97
3	Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.	J Med Chem	2014	0.93
4	Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.	Antimicrob Agents Chemother	2012	0.93
5	Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.	Antimicrob Agents Chemother	2013	0.87
6	Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.	J Med Chem	2014	0.83
7	Lead optimization of 1,4-azaindoles as antimycobacterial agents.	J Med Chem	2014	0.82
8	4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.	J Med Chem	2014	0.82
9	N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.	J Med Chem	2014	0.82
10	Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.	J Med Chem	2013	0.78